NEOGENOMICS INC — Director's Dealing 2017

Oct 18, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-10-17

Reporting Person: McKenzie Kathryn B (Principal Accounting Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$9.52	2022-10-17	Common Stock (25000)		Direct

Footnotes

F1: On October 17, 2017, Ms. McKenzie was granted an option to purchase 25,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.